329 related articles for article (PubMed ID: 9817738)
21. Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma.
Hirst SJ; Lee TH
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 3):S201-6. PubMed ID: 9817746
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics of beta2-agonist: key focus on signaling pathways.
Bhatnagar P; Guleria R; Kukreti R
Pharmacogenomics; 2006 Sep; 7(6):919-33. PubMed ID: 16981850
[TBL] [Abstract][Full Text] [Related]
23. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A
Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561
[TBL] [Abstract][Full Text] [Related]
24. Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy.
Kume H; Fukunaga K; Oguma T
Pharmacol Ther; 2015 Dec; 156():75-89. PubMed ID: 26432616
[TBL] [Abstract][Full Text] [Related]
25. Effects of genetic polymorphism on ex vivo and in vivo function of beta2-adrenoceptors in asthmatic patients.
Lipworth BJ; Hall IP; Tan S; Aziz I; Coutie W
Chest; 1999 Feb; 115(2):324-8. PubMed ID: 10027427
[TBL] [Abstract][Full Text] [Related]
26. Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells.
Kaur M; Chivers JE; Giembycz MA; Newton R
Mol Pharmacol; 2008 Jan; 73(1):203-14. PubMed ID: 17901197
[TBL] [Abstract][Full Text] [Related]
27. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
[TBL] [Abstract][Full Text] [Related]
28. Beta-adrenoceptor responses of the airways: for better or worse?
Broadley KJ
Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
[TBL] [Abstract][Full Text] [Related]
29. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
30. Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
Faisy C; Risse PA; Naline E; Guerot E; Fagon JY; Devillier P; Advenier C
Life Sci; 2006 Oct; 79(20):1929-35. PubMed ID: 16820175
[TBL] [Abstract][Full Text] [Related]
31. Receptors in asthmatic airways.
Goldie RG
Am Rev Respir Dis; 1990 Mar; 141(3 Pt 2):S151-6. PubMed ID: 2155564
[TBL] [Abstract][Full Text] [Related]
32. Allergic airway inflammation and beta-adrenoceptor dysfunction.
Brusasco V; Crimi E; Baroffio M
Cell Biochem Biophys; 2006; 44(1):129-38. PubMed ID: 16456241
[TBL] [Abstract][Full Text] [Related]
33. Beyond the dogma: novel beta2-adrenoceptor signalling in the airways.
Giembycz MA; Newton R
Eur Respir J; 2006 Jun; 27(6):1286-306. PubMed ID: 16772391
[TBL] [Abstract][Full Text] [Related]
34. [Beta2-agonists--what does their chemical structure determine?].
Weglarz L; Grzanka A; Rogala B; Wilczok T
Postepy Hig Med Dosw (Online); 2004; 58():372-80. PubMed ID: 15536395
[TBL] [Abstract][Full Text] [Related]
35. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
Sin DD; Man SF
Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
[TBL] [Abstract][Full Text] [Related]
36. New insights into beta-adrenoceptors in smooth muscle: distribution of receptor subtypes and molecular mechanisms triggering muscle relaxation.
Tanaka Y; Horinouchi T; Koike K
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):503-14. PubMed ID: 16026507
[TBL] [Abstract][Full Text] [Related]
37. [Mechanisms of desensitization of beta-adrenergic receptors].
Cros G
Bull Eur Physiopathol Respir; 1985; 21(5):35s-43s. PubMed ID: 2865991
[TBL] [Abstract][Full Text] [Related]
38. beta(2)-adrenoceptor agonist-induced upregulation of tachykinin NK(2) receptor expression and function in airway smooth muscle.
Katsunuma T; Roffel AF; Elzinga CR; Zaagsma J; Barnes PJ; Mak JC
Am J Respir Cell Mol Biol; 1999 Sep; 21(3):409-17. PubMed ID: 10460759
[TBL] [Abstract][Full Text] [Related]
39. A CREB-mediated increase in miRNA let-7f during prolonged β-agonist exposure: a novel mechanism of β
Kim D; Cho S; Woo JA; Liggett SB
FASEB J; 2018 Jul; 32(7):3680-3688. PubMed ID: 29455573
[TBL] [Abstract][Full Text] [Related]
40. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
